Inspiratory Fraction Correlates With Exercise Capacity in Patients With Stable Moderate to Severe COPD
|
|
- Edward Shelton
- 6 years ago
- Views:
Transcription
1 Inspiratory Fraction Correlates With Exercise Capacity in Patients With Stable Moderate to Severe COPD Yan Zhang MD, Xing-Guo Sun MD, Wen-Lan Yang MD, Xiao-Yue Tan MD, and Jin-Ming Liu MD BACKGROUND: Exercise intolerance is the hallmark of COPD. Static lung hyperinflation and increased dynamic hyperinflation during exercise are associated with reduced functional capacity in COPD patients. Inspiratory capacity correction for the total lung capacity, defined as inspiratory fraction (IF), may be functionally more representative than other traditional indices in these patients. OBJECTIVE: To investigate the association between IF and exercise capacity in patients with stable, moderate to severe COPD. METHODS: Fifty COPD subjects and 34 healthy volunteers constituted the study cohort. Pulmonary function and cardiopulmonary exercise testing were performed, and ventilation and gas exchange parameters were measured. RESULTS: IF was significantly correlated with percent-of-predicted peak oxygen consumption (V ) in the subjects with COPD (r 0.52, P <.001). IF was an independent predictor of reduced exercise capacity in the COPD subjects, and was more sensitive and specific than percent-of-predicted FEV 1. Statistical analysis generated the equation: percent-of-predicted peak V 65.9 IF 0.45 percent-of-predicted FEV (R C , P <.001). The subjects with IF < 0.23 had more severe lung hyperinflation and less exercise capacity than the subjects with IF > At peak exercise, the breathing frequencies of the 2 groups were similar, whereas the low-if subjects had reduced peak minute ventilation and peak tidal volume, relative to the high-if subjects. CONCLUSIONS: Compared to FEV 1, IF is a robust factor to reflect lung hyperinflation and to estimate the exercise capacity of subjects with stable moderate to severe COPD. Key words: COPD; inspiratory fraction; lung hyperinflation; cardiopulmonary exercise test; inspiratory capacity. [Respir Care 2013;58(11): Daedalus Enterprises] Introduction COPD is recognized as the fourth leading cause of death worldwide and a major chronic respiratory disorder due to different diseases causing medical disability. COPD is characterized by air-flow limitation that is poorly reversible, The authors are affiliated with the Department of Respiratory Medicine, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China, with the exception of Dr Sun, who is affiliated with the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California. The authors have disclosed no conflicts of interest. Correspondence: Jin-Ming Liu MD, Department of Respiratory Medicine, Shanghai Pulmonary Hospital, Tongji University, 507 Zhengmin Road, Shanghai , China. jinmingliu_sh@hotmail.com. DOI: /respcare progressive, and associated with an abnormal inflammatory response of the lung to noxious particles, such as the materials released from smoking. 1 The hallmark of COPD is exercise intolerance and exertional dyspnea, which are due to complex interactions between impaired ventilatory, cardiovascular, and peripheral muscle responses. The major abnormality of respiratory muscle dysfunction in COPD patients is the mechanical disadvantage caused by lung hyperinflation. Static lung hyperinflation at rest and increased dynamic hyperinflation during exercise are associated with reduced functional capacity in these patients. 2 Over the decades, it has been widely accepted that traditional measures of air-flow obstruction, such as FEV 1 and FEV 1 /FVC, are repeatable and reliable for the diagnosis and prognosis of COPD. However, increasing evidence demonstrates that FEV 1 /FVC does not reflect the level of lung hyperinflation and is poorly correlated with exercise capacity and exertional dyspnea in COPD patients. 1,2 RESPIRATORY CARE NOVEMBER 2013 VOL 58 NO
2 Recently, inspiratory capacity (IC) at rest and during exercise has been shown to be superior to traditional predictive parameters like FEV 1. 3 IC reflects the level of lung hyperinflation and is associated with the functional reserve in patients with COPD. Moreover, the ratio of IC to total lung capacity (IC/TLC, called the inspiratory fraction or IF) provides a better characterization of the volume fraction available for inspiration than does IC alone, 4 and IF predicts exercise capacity in patients with moderate to severe COPD. In the current study we compared the functional parameters of ventilation, gas exchange, and exercise capacity in patients with stable moderate to severe COPD. We also analyzed the breathing patterns and exertional dyspnea of these patients with standard pulmonary function tests (PFTs) and cardiopulmonary exercise testing (CPET). Our objective was to investigate the relationship between IC, IF, and other parameters and the exercise capacity of patients with COPD, to determine if IF is a robust predictor of exercise capacity in COPD patients. Methods The protocol was approved by our hospital s ethics review board. All subjects signed written informed consent before enrollment. Patients diagnosed as having COPD stage II (n 16) and stage III (n 34) at the Department of Respiratory Medicine, Shanghai Pulmonary Hospital, between July 2010 and June 2011, were recruited for this study. Diagnosis and classification were based on the Global Initiative for Chronic Obstructive Lung Disease 2010 guidelines. 5 All subjects accepted regular treatment and had stable COPD for at least 4 weeks prior to enrollment. More than 400 patients were screened for this study, by analyzing patient history, PFTs, heart color Doppler ultrasound, and computed tomograms. Patients with other diseases that cause breathing discomfort and impaired exercise capacity, such as asthma, pulmonary arterial hypertension, interstitial lung disease, other concomitant lung disease, heart failure, metabolic disorders, and/or skeletal muscle diseases, were excluded. As a control group, 34 healthy volunteers of similar ages participated in the study. Professional athletes and laborers were excluded. Age, sex, body weight, and height of all subjects were recorded, and body mass index was calculated. PFTs were performed (MasterScreen-PFT, Erich Jaeger, Friedberg, Germany) before and after bronchodilator. Every subject completed at least 3 acceptable tests, with an interval of 1 min. The variability between the 3 tests was 5%, and the results of the best trial were recorded. Collected parameters included FVC, FEV 1, FEV 1 /FVC, maximal voluntary ventilation (MVV), IC, TLC, residual volume (RV), RV/TLC, and diffusing capacity of the lung for carbon QUICK LOOK Current knowledge Exercise intolerance is common and decreases quality of life in patients with COPD. Static lung hyperinflation and increased dynamic hyperinflation during exercise reduce functional capacity in COPD patients. What this paper contributes to our knowledge Inspiratory fraction (inspiratory capacity/total lung capacity) independently predicted reduced exercise capacity in patients with moderate to severe COPD. An inspiratory fraction of 0.23 was associated with worse lung hyperinflation and reduced exercise capacity. monoxide (D LCO ) (corrected for hemoglobin). PFT parameters are expressed as percent-of-predicted values, which were calculated using the equations designed for Chinese adults in Symptom-limited CPET was conducted on a cycle ergometer, using a cardiopulmonary exercise testing system (MasterScreen-CPX, Erich Jaeger, Friedberg, Germany) and a gas analysis system (SBx/CPX, Erich Jaeger, Friedberg, Germany). 7 The increasing work rate was individually selected from 10 W/min to 25 W/min, to provide a total exercise duration of 8 12 min. During the whole procedure we monitored a 12-lead online electrocardiogram, blood pressure, S p, and gas exchange. Gas exchange data were recorded, breath-by-breath, and averaged over 10-second intervals, followed by further analysis The tests were terminated if the subject had any of the following conditions: ischemic electrocardiogram changes (ST depression of 2 mm with chest pain, or ST depression of 3 mm without chest pain), frequent premature ventricular contractions, conduction disorders, systolic pressure 250 mm Hg, diastolic pressure 120 mm Hg, a fall in systolic pressure 20 mm Hg from the highest value obtained during the test, and/or an S p 80%. Typical symptoms for stopping were leg fatigue, weakness, or shortness of breath. The CPET variables were peak load, peak oxygen uptake (V ), peak O 2 pulse, minute ventilation (V E), breathing frequency, tidal volume (V T ), heart rate, and heart rate reserve (predicted heart rate peak heart rate) (predicted heart rate 220 age). Anaerobic threshold was determined by the V-slope method. 11 The intensity of dyspnea at peak exercise was described as peak V E/MVV. CPET parameters were expressed as percent-of-predicted values, which were calculated with the equations from the American Thoracic Society/American College of Chest Physicians in RESPIRATORY CARE NOVEMBER 2013 VOL 58 NO 11
3 Table 1. Demographics and Pulmonary Function and Cardiopulmonary Exercise Testing Results From COPD Subjects Versus Normal Subjects COPD Subjects n 50 Normal Subjects n 34 P Male/female 45/5 26/8.09 Age, y Body mass index, kg/m FVC, % predicted FEV 1, % predicted FEV 1 /FVC, % TLC, % predicted Inspiratory capacity, % predicted Inspiratory fraction RV, % predicted RV/TLC, % D LCO, % predicted P a,mmhg P ac,mmhg Peak work, W Peak work, % predicted Peak V, ml/min 1, , Peak V, % predicted Peak heart rate, beats/min Peak V E, L/min Peak breathing frequency, breaths/min Peak V T,L Peak O 2 pulse, ml/beat Peak O 2 pulse, % predicted Peak V E/maximum voluntary ventilation Anaerobic threshold, ml/min , V E/V C at anaerobic threshold Values are mean SD. TLC total lung capacity RV residual volume D LCO diffusing capacity of the lung for carbon monoxide V E minute volume V O 2 consumption V T tidal volume V C CO 2 clearance All statistical analyses were performed with statistics software (SPSS 19.0, SPSS, Chicago, Illinois). Data are expressed as mean SD. P values between groups were calculated using the chi-square test or the unpaired Student t test. Pearson correlation coefficients were calculated to assess the correlations between variables. Backward, stepwise, multiple linear regression was performed to determine the independent predictors. Receiver operating characteristic (ROC) curves were created for selected variables, to evaluate the sensitivity and specificity of PFT parameters as predictors for percent-of-predicted peak V. 13 The Youden index was calculated to find the cutoffs for variables. The Youden index is defined as the maximum vertical distance between the ROC curve and the diagonal or chance line, and is calculated as maximum (sensitivity specificity 1). 14 A P value.05 was considered statistically significant. PFT and CPET Values Results Fifty subjects with stable, moderate or severe COPD and 35 healthy volunteers participated in this study. Table 1 shows the demographics of all the subjects and the results of PFTs and CPET. There were no significant differences between the 2 groups in sex, age, or body mass index. Percent-of-predicted FEV 1 (FEV 1 %) in the COPD subjects demonstrated moderate to very severe obstruction (FEV 1 % range 32 75%). Nearly all the COPD subjects RESPIRATORY CARE NOVEMBER 2013 VOL 58 NO
4 Fig. 1. Inspiratory fraction versus percent-of-predicted peak oxygen uptake (V ) in subjects with stable, moderate to severe COPD. had lung volume measurements suggestive of air trapping (percent-of-predicted RV range %, n 48), and D LCO was decreased in nearly half (percent-of-predicted D LCO 37% to 79%, n 24). In the CPET we observed significant reductions in peak work, percent-of-predicted peak work, peak V, percentof-predicted peak V, and anaerobic threshold in the COPD subjects, compared to the normal subjects (P.001). Twenty-six percent of the COPD subjects displayed a severe reduction in percent-of-predicted peak V ( 65%, n 13). 10 The ratio of V E to CO 2 production (V E/V C )at anaerobic threshold in the COPD subjects was significantly higher than in the normal subjects. At peak exercise, gas exchange analysis showed that there was no significant difference for peak breathing frequency between the 2 groups (P.33). However, peak V E ( L/ min) and peak V T ( L) in the COPD subjects were dramatically decreased, compared to the control group ( L/min and L, respectively, P.001). The peak V E/MVV of 98% of the COPD subjects was 0.7, suggesting a severely reduced breathing reserve in the COPD subjects at peak exercise. 12 Moreover, the peak V E/MVV of the COPD subjects was worse than the control group ( and , respectively, P.001). Association Between PFT Parameters and Percent-of- Predicted Peak V in the COPD Subjects The percent-of-predicted peak V was significantly related to some PFT parameters, including percent-of-predicted IC (IC%) (r 0.43, P.002), percent-of-predicted RV (r 0.52, P.001), percent-of-predicted TLC Fig. 2. Receiver operating characteristic curves for inspiratory fraction, percent-of-predicted inspiratory capacity, and percent-ofpredicted FEV 1 for predicting the change in percent-of-predicted peak oxygen uptake ( 65%). The areas under the curve are (95% CI , P.001), (95% CI , P.001), and (95% CI , P.001), and the cutoffs are 0.23, 43%, and 60%, respectively. (r 0.25, P.08), IF (r 0.52, P.001, Fig. 1), and FEV 1 %(r 0.54, P.001). Backward stepwise multiple linear regression analysis generated the equation: Percent-of-predicted peak V 65.9 IF 0.45 FEV 1 % 35.8 R C 2 (the adjusted determination coefficient) 0.39 and P.001. The results reveal that IF and FEV 1 % are independent predictors of exercise capacity in COPD subjects. IF as a Predictor of Exercise Capacity in COPD Subjects Based on the above findings, we then compared the sensitivity and specificity of IF, IC%, and FEV 1 %aspredictors of percent-of-predicted peak V in the COPD subjects, by analyzing the ROC curves. The areas under the curve were (95% CI , P.001), (95% CI , P.001), and (95% CI , P.001), respectively (Fig. 2). When we chose 0.23 as the cutoff for IF, the sensitivity, specificity, 1926 RESPIRATORY CARE NOVEMBER 2013 VOL 58 NO 11
5 Table 2. Demographics and Pulmonary Function and Cardiopulmonary Exercise Testing Results From Subjects With Inspiratory Fraction Less Than Versus More Than 0.23 Inspiratory Fraction 0.23 n n 32 P Age, y Body mass index, kg/m FVC, % predicted FEV 1, % predicted FEV 1 /FVC, % TLC, % predicted Inspiratory capacity, % predicted Inspiratory fraction RV, % predicted RV/TLC, % D LCO, % predicted P a,mmhg P ac,mmhg Peak work, W Peak work, % predicted Peak V, ml/min 1, , Peak V, % predicted Peak heart rate, beats/min Peak heart rate, % predicted Heart rate reserve, beats/min Peak V E, L/min Peak breathing frequency, breaths/min Peak V T,L Peak O 2 pulse, ml/beats Peak O 2 pulse, % predicted Peak V E/maximum voluntary ventilation Anaerobic threshold, L/min V E/V C at anaerobic threshold Stopping reason, no..03 Breathing discomfort Leg fatigue 3 15 Breathing discomfort and leg fatigue 2 6 Values are mean SD. TLC total lung capacity RV residual volume D LCO diffusing capacity of the lung for carbon monoxide V O 2 consumption V E minute volume V T tidal volume V C CO 2 clearance and Youden index of IF as an independent factor were 0.923, 0.837, and 0.76, respectively. Similarly, the cutoff for FEV 1 % was 43%, and the sensitivity, specificity, and Youden index were 0.722, and 0.651, respectively. The cutoff of IC% was 63% and the sensitivity, specificity, and Youden index were 0.722, 0.929, and 0.651, respectively. The data reveal that IF is the best factor among PFT parameters for predicting exercise capacity in COPD subjects. Comparison of PFT and CPET Parameters in COPD Subjects With High or Low IF According to the calculated Youden index, we chose 0.23 as the cutoff for IF, and divided the COPD subjects into 2 groups: IF 0.23 (n 18), and IF 0.23 (n 32). Table 2 shows the respective PFT parameters of the 2 groups: FEV 1 % was % and %, percent-of-predicted TLC was % and RESPIRATORY CARE NOVEMBER 2013 VOL 58 NO
6 Fig. 3. Tidal volume (V T ) during cardiopulmonary exercise testing in subjects with COPD and an inspiratory fraction 0.23 or The duration of rest was an average of 120 s before ending the period. The duration of warm-up was an average of 30 s before ending the period. The anaerobic threshold was determined by the V-slope method. The duration of peak exercise was an average of 30 s before the peak load. The whisker bars indicate the 95% CIs. * P %, percent-of-predicted RV was % and %, and IC% was % and %. These data suggest that the IF 0.23 group had worse air-flow obstruction and higher lung hyperinflation than the IF 0.23 group. The CPET results reveal that the peak percent-of-predicted V of 6 subjects in the IF 0.23 group was 65%, and that of the rest was 65%. The percent-of-predicted peak V of one subject in the IF 0.23 group was 65%, and that of the rest was 65%. Breathing pattern analysis at peak exercise showed that the peak breathing frequency was not significantly different between the 2 COPD groups (P.29). However, the peak V E ( L/min) of the IF 0.23 group was significantly lower than that of the IF 0.23 group ( L/min) (P.001), and V T at anaerobic threshold and peak exercise ( L and L) of the IF 0.23 group were significantly lower than those ( L and L) of the IF 0.23 group (P.01 and 0.001, Fig. 3.). The patterns of the change of V T and breathing frequency in CPET (Fig. 4) revealed that the V T of COPD subjects with IF 0.23 did not increase substantially when the exercise load was increasing, and that V T at peak exercise almost reached the IC at rest. In contrast, the V T of COPD subjects with IF 0.23 increased when the exercise load was increasing, and the V T at peak Fig. 4. Representative tidal volume (V T ) and breathing frequency (f) patterns of subjects with COPD and normal subjects during cardiopulmonary exercise testing. A: COPD subject with inspiratory fraction (IF) 0.15, inspiratory capacity (IC) 1.27, and a 15 W/min work increase. B: COPD subject with IF 0.35, IC 2.49, and a 20 W/ min work increase. C: Normal subject with IF 0.44, IC 2.73, and a 20 W/min work increase. exercise was lower than the IC at rest. The pattern of V T change in the IF 0.23 group subjects was comparable to normal subjects, whereas the peak V T of the IF 0.23 group was smaller than that of control subjects. Gas exchange analysis showed that although anaerobic threshold was not statistically different between the 2 COPD groups (P.09), V E/V C was higher in the IF 0.23 group than the IF 0.23 group ( vs , P.045). In addition, 72% of COPD the IF 0.23 group subjects and 34% of the IF 0.23 group subjects stopped exercise due to shortness of breath. 2% of the IF 0.23 group subjects and 47% of the IF 0.23 group subjects stopped the exercise because of leg fatigue. The results suggested that the reason for stopping exercise was significantly different between COPD subjects with high or low IF (P.05) RESPIRATORY CARE NOVEMBER 2013 VOL 58 NO 11
7 Discussion Although many factors contribute to exercise intolerance in COPD patients, such as impairment of pulmonary function, cardiovascular diseases, metabolic disorders, skeletal muscle diseases, or the combination of several diseases, one major reason is the limitation of pulmonary function. 15 In the present study we excluded COPD patients with certain severe systemic diseases that impair pulmonary function and reduce exercise capacity. As a key characteristic of decreased pulmonary function in COPD patients, expiratory flow reduction progressively promotes air trapping and lung hyperinflation, so COPD patients display decreased IC and increased RV and TLC. At rest these patients can extend the expiratory duration to fully exhale, but during exercise their only way to increase V E is to increase breathing frequency, due to the limitation of the V T increment caused by a reduced IC. Therefore, the expiratory time is further decreased and lung hyperinflation and air trapping get worse. 16 Meanwhile, increased end-expiratory lung volume in COPD patients leads to intrinsic PEEP, which increases the work of breathing and causes respiratory muscle fatigue and insufficient gas exchange during exercise. The combination of these events leads to limited exercise capacity and dyspnea. 17 CPET with gas exchange analysis is a powerful technique to evaluate cardiovascular and pulmonary function. 7 CPET can noninvasively assess heart and lung function, exercise limitation, hypoperfusion of the lung and systemic circulation, and response to therapy, and help diagnose early pulmonary hypertension and assess surgery risk. The V increase measured at external respiration during exercise provides information on dynamic changes of internal metabolism. Moreover, peak V and percent-of-predicted peak V collected during symptom-limited CPET are the gold standard for evaluating exercise capacity. 12 Our previous studies also demonstrated that dynamic oxygen uptake parameters during exercise are effective indices for evaluating heart and lung function in COPD patients. 18,19 We chose percentof-predicted peak V as a potential factor to evaluate exercise capacity. As an index for lung hyperinflation, IC is better than other PFT parameters in reflecting and predicting reduced exercise capacity and ventilation impairment in COPD patients However, COPD patients with similar IC might have very different TLC, so IC/TLC is better than IC alone to reflect the increase of end-expiratory lung volume. Our findings show that IF was significantly correlated with percent-of-predicted peak V and could be employed as an independent factor to predict reduced exercise capacity in patients with moderate to severe COPD. In addition, IF was more sensitive than IC% in predicting exercise capacity in COPD patients, according to the ROC curve analysis. Our ROC curve analysis and Youden index calculation indicate that IF is also more sensitive than FEV 1 % in predicting exercise capacity in COPD patients. This suggests that the change of lung hyperinflation is more predictive of the improvement of ventilation impairment than the change of expiratory air flow in stable COPD patients after treatment with bronchodilators. A group of studies showed that, compared to FEV 1, IC was a potential factor in evaluating the effects of bronchodilators in COPD patients The sensitivity, specificity, and Youden index of IF in predicting exercise capacity in COPD subjects were 0.861, 0.929, and 0.79 when 0.23 was selected as the IF cutoff. This suggests that 0.23 is a proper cutoff for IF as a predictor. Further comparison showed that the COPD subjects with IF 0.23 had worse lung hyperinflation, ventilation impairment, and exercise capacity reduction, indicating that IF is a robust predictor of COPD severity. Our findings are consistent with those of Albuquerque et al, who reported that an IF 0.28 was a good predictor of exercise intolerance in COPD subjects. 4 Also, Vassaux et al found that COPD subjects with an IF 0.25 possessed worse percent-of-predicted peak V and peak O 2 pulse than subjects with an IF Another study found that IF was an independent predictor of mortality risk in COPD subjects, and that COPD subjects with an IF 0.25 had worse pulmonary function and higher mortality risk. 27 The IF cutoff we found in our study was different from these other reports, which might be because of a different cohort size, different ethnicities of the subjects, and/or different COPD phenotypes. Our CPET results showed no significant difference in peak breathing frequency between the 2 COPD groups. However, the peak V T and peak V E of COPD subjects with an IF 0.23 were lower than those with an IF Seventy-two percent of the IF 0.23 group stopped the exercise due to shortness of breath, indicating that the limited V T increase was not sufficient to meet their ventilation demand during exercise, and the increased neuromuscular dissociation. We also noticed that (see Fig. 4), due to the reduction of IC, the increment of V T in the IF 0.23 group was significantly smaller than that in the IF 0.23 group. Also, the V T in the IF 0.23 group was very close to their IC, indicating that subjects in the IF 0.23 group had more severe dynamic hyperinflation. Therefore, an increased respiratory muscle work in the IF 0.23 group was required to overcome the lung dynamic elastance caused by gradually increasing endexpiratory lung volume. 28 Clearly, the only way of increasing exercise capacity in the IF 0.23 group was to increase the breathing frequency earlier, and they would stop exercise earlier because of respiratory distress. Meanwhile, a worse ventilation-to-perfusion ratio could have caused exertional dyspnea, thereby dramatically reducing exercise capacity. Because the V E and carbon dioxide production were simultaneously limited in the exercise, it was difficult to compare V E/ V C at anaerobic threshold between the 2 COPD groups. In addition, the percent-of-predicted peak O 2 pulse in the RESPIRATORY CARE NOVEMBER 2013 VOL 58 NO
8 IF 0.23 group was less than that of the IF 0.23 group. This might be caused by severe hyperinflation-induced reduction of left ventricular end-diastolic volume, reduced right heart blood volume, and/or increased left ventricular after-load. 26,29 Due to our small sample size, we cannot rule out that another cutoff value of IF and other physiological variables might be superior to IF 0.23 to evaluate exercise capacity in patients with stable, moderate to severe COPD. The reasons for stopping exercise were significantly different between the 2 COPD groups, whereas there was no significant difference in peak V E/MVV. It is possible that our cohort size was not big enough, or that the specificity of peak V E/MVV is not significant. Therefore, it is critical to further study the effects of dynamic hyperinflation on exercise capacity. Conclusions IF significantly correlates with and independently predicts exercise capacity in patients with stable, moderate to severe COPD. Compared to the COPD subjects with IF 0.23, the subjects with IF 0.23 had worse lung hyperinflation, less exercise capacity, and more reduced peak V T, peak V E, and percent-of-predicted peak O 2 pulse. Our findings support the hypothesis that IF is a useful predictor of exercise capacity in COPD patients, and might help physicians choose individual treatment plans. ACKNOWLEDGMENTS We thank the study participants and the technicians of our pulmonary function laboratory. REFERENCES 1. Cooper CB. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function. Am J Med 2006;119(10 Suppl 1): Bauerle O, Chrusch CA, Younes M. Mechanisms by which COPD affects exercise tolerance. Am J Respir Crit Care Med 1998;157(1): Diaz O, Villafranca C, Ghezzo H, Borzone G, Leiva A, Milic-Emil J, et al. Role of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest. Eur Respir J 2000;16(2): Albuquerque AL, Nery LE, Villaca DS, Machado TY, Oliveira CC, Paes AT, et al. Inspiratory fraction and exercise impairment in COPD patients GOLD stages II-III. Eur Respir J 2006;28(5): Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated com/download.asp?intid 504. Accessed August 19, Mu K, Liu S. Summary of Chinese pulmonary function normal values. Beijing Medical University and Peking Union Medical College Press; 1990: Wasserman K, E. Hansen J, Sue DY, Stringer WW, J. Whipp B. Principles of exercise testing and interpretation: including pathophysiology and clinical applications, 4th edition. Philadelphia: Lippincott Williams & Wilkinks 2008; Sun XG, Hansen JE, Beshai JF, Wasserman K. Oscillatory breathing and exercise gas exchange abnormalities prognosticate early mortality and morbidity in heart failure. J Am Coll Cardiol 2010;55(17): Sun XG, Hansen JE, Garatachea N, Storer TW, Wasserman K. Ventilatory efficiency during exercise in healthy subjects. Am J Respir Crit Care Med 2002;166(11): Sun XG, Hansen JE, Oudiz RJ, Wasserman K. Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation 2001;104(4): Beaver WL, Wasserman K, Whipp BJ. A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol 1986;60(6): ATS/ACCP. Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003;167(2): Jensen K, Muller HH, Schafer H. Regional confidence bands for ROC curves. Stat Med 2000;19(4): Fluss R, Faraggi D, Reiser B. Estimation of the Youden Index and its associated cutoff point. Biom J 2005;47(4): Jones NL, Killian KJ. Exercise limitation in health and disease. N Engl J Med 2000;343(9): Puente-Maestu L, Garcia de Pedro J, Martinez-Abad Y, Ruiz de Ona JM, Llorente D, Cubillo JM. Dyspnea, ventilatory pattern, and changes in dynamic hyperinflation related to the intensity of constant work rate exercise in COPD. Chest 2005;128(2): Loring SH, Garcia-Jacques M, Malhotra A. Pulmonary characteristics in COPD and mechanisms of increased work of breathing. J Appl Physiol 2009;107(1): Liu P, Liu J, Yang W, Sun X. Application of VO 2 in evaluating the heart and lung function of severe COPD patients. Inter J Respir 2011;31: Liu P, Liu J, Yang W, Sun X. Study of the characteristics of dynamic oxygen uptake in severe COPD patients during exercise. Inter J Respir 2011;31: O Donnell D E. Dynamic lung hyperinflation and its clinical implication in COPD. Rev Mal Respir 2008;25(10): Peters MM, Webb KA, O Donnell DE. Combined physiological effects of bronchodilators and hyperoxia on exertional dyspnoea in normoxic COPD. Thorax 2006;61(7): Yetkin O, Gunen H. Inspiratory capacity and forced expiratory volume in the first second in exacerbation of chronic obstructive pulmonary disease. Clin Respir J 2008;2(1): Newton MF, O Donnell DE, Forkert L. Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation. Chest 2002;121(4): O Donnell DE, Fluge T, Gerken F, Hamilton A, Webb K, Aguilaniu B, et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 2004;23(6): Tashkin DP. Impact of tiotropium on the course of moderate-to-very severe chronic obstructive pulmonary disease: the UPLIFT trial. Expert Rev Respir Med 2010;4(3): Vassaux C, Torre-Bouscoulet L, Zeineldine S, Cortopassi F, Paz- Diaz H, Celli BR, et al. Effects of hyperinflation on the oxygen pulse as a marker of cardiac performance in COPD. Eur Respir J 2008; 32(5): Casanova C, Cote C, de Torres JP, Aguirre-Jaime A, Marin JM, Pinto-Plata V, et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;171(6): O Donnell DE, Webb KA. The major limitation to exercise performance in COPD is dynamic hyperinflation. J Appl Physiol 2008; 105(2): ; discussion Barr RG, Bluemke DA, Ahmed FS, Carr JJ, Enright PL, Hoffman EA, et al. Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med 2010;362(3): RESPIRATORY CARE NOVEMBER 2013 VOL 58 NO 11
Exercise Stress Testing: Cardiovascular or Respiratory Limitation?
Exercise Stress Testing: Cardiovascular or Respiratory Limitation? Marshall B. Dunning III, Ph.D., M.S. Professor of Medicine & Physiology Medical College of Wisconsin What is exercise? Physical activity
More informationFOLLOW-UP MEDICAL CARE OF SERVICE MEMBERS AND VETERANS CARDIOPULMONARY EXERCISE TESTING
Cardiopulmonary Exercise Testing Chapter 13 FOLLOW-UP MEDICAL CARE OF SERVICE MEMBERS AND VETERANS CARDIOPULMONARY EXERCISE TESTING WILLIAM ESCHENBACHER, MD* INTRODUCTION AEROBIC METABOLISM ANAEROBIC METABOLISM
More informationIncreased difference between slow and forced vital capacity is associated with reduced exercise tolerance in COPD patients
Yuan et al. BMC Pulmonary Medicine 2014, 14:16 RESEARCH ARTICLE Open Access Increased difference between slow and forced vital capacity is associated with reduced exercise tolerance in COPD patients Wei
More informationClinical exercise testing
Basic principles of clinical exercise testing Clinical exercise testing This article is adapted from the on Basic principles of clinical exercise testing organised in Rome, March 2 4, 2006. Original slides,
More informationYuriy Feschenko, Liudmyla Iashyna, Ksenia Nazarenko and Svitlana Opimakh
2018; 7(1): 74-78 ISSN (E): 2277-7695 ISSN (P): 2349-8242 NAAS Rating: 5.03 TPI 2018; 7(1): 74-78 2018 TPI www.thepharmajournal.com Received: 11-11-2017 Accepted: 12-12-2017 Yuriy Feschenko Liudmyla Iashyna
More informationPFT Interpretation and Reference Values
PFT Interpretation and Reference Values September 21, 2018 Eric Wong Objectives Understand the components of PFT Interpretation of PFT Clinical Patterns How to choose Reference Values 3 Components Spirometry
More informationDifference Between The Slow Vital Capacity And Forced Vital Capacity: Predictor Of Hyperinflation In Patients With Airflow Obstruction
ISPUB.COM The Internet Journal of Pulmonary Medicine Volume 4 Number 2 Difference Between The Slow Vital Capacity And Forced Vital Capacity: Predictor Of Hyperinflation In Patients With Airflow Obstruction
More informationPULMONARY FUNCTION TESTING. Purposes of Pulmonary Tests. General Categories of Lung Diseases. Types of PF Tests
PULMONARY FUNCTION TESTING Wyka Chapter 13 Various AARC Clinical Practice Guidelines Purposes of Pulmonary Tests Is lung disease present? If so, is it reversible? If so, what type of lung disease is present?
More informationTeacher : Dorota Marczuk Krynicka, MD., PhD. Coll. Anatomicum, Święcicki Street no. 6, Dept. of Physiology
Title: Spirometry Teacher : Dorota Marczuk Krynicka, MD., PhD. Coll. Anatomicum, Święcicki Street no. 6, Dept. of Physiology I. Measurements of Ventilation Spirometry A. Pulmonary Volumes 1. The tidal
More informationWhat do pulmonary function tests tell you?
Pulmonary Function Testing Michael Wert, MD Assistant Professor Clinical Department of Internal Medicine Division of Pulmonary, Critical Care, and Sleep Medicine The Ohio State University Wexner Medical
More informationPulmonary Function Testing: Concepts and Clinical Applications. Potential Conflict Of Interest. Objectives. Rationale: Why Test?
Pulmonary Function Testing: Concepts and Clinical Applications David M Systrom, MD Potential Conflict Of Interest Nothing to disclose pertinent to this presentation BRIGHAM AND WOMEN S HOSPITAL Harvard
More informationDyspnea is a common exercise-induced
MK pg 214 Mædica - a Journal of Clinical Medicine STATE-OF-THE-ART Cardiopulmonary exercise testing in differential diagnosis of dyspnea Nora TOMA, MD; Gabriela BICESCU, MD, PhD; Raluca ENACHE, MD; Ruxandra
More informationPulmonary Function Testing. Ramez Sunna MD, FCCP
Pulmonary Function Testing Ramez Sunna MD, FCCP Lecture Overview General Introduction Indications and Uses Technical aspects Interpretation Patterns of Abnormalities When to perform a PFT 1. Evaluation
More informationPulmonary Rehabilitation Focusing on Rehabilitative Exercise Prof. Richard Casaburi
Pulmonary Rehabilitation 1 Rehabilitation Clinical Trials Center Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Torrance, California, USA Historical perspective on rehabilitative
More informationBasics of Cardiopulmonary Exercise Test Interpretation. Robert Kempainen, MD Hennepin County Medical Center
Basics of Cardiopulmonary Exercise Test Interpretation Robert Kempainen, MD Hennepin County Medical Center None Conflicts of Interest Objectives Explain what normally limits exercise Summarize basic protocol
More informationKey words: exercise therapy; exercise tolerance; lung diseases; obstructive; oxygen consumption; walking
Exercise Outcomes After Pulmonary Rehabilitation Depend on the Initial Mechanism of Exercise Limitation Among Non-Oxygen-Dependent COPD Patients* John F. Plankeel, MD; Barbara McMullen, RRT; and Neil R.
More informationClinical pulmonary physiology. How to report lung function tests
Clinical pulmonary physiology or How to report lung function tests Lung function testing A brief history Why measure? What can you measure? Interpretation/ reporting Examples and case histories Exercise
More information6- Lung Volumes and Pulmonary Function Tests
6- Lung Volumes and Pulmonary Function Tests s (PFTs) are noninvasive diagnostic tests that provide measurable feedback about the function of the lungs. By assessing lung volumes, capacities, rates of
More informationPULMONARY FUNCTION. VOLUMES AND CAPACITIES
PULMONARY FUNCTION. VOLUMES AND CAPACITIES The volume of air a person inhales (inspires) and exhales (expires) can be measured with a spirometer (spiro = breath, meter = to measure). A bell spirometer
More informationBasic approach to PFT interpretation. Dr. Giulio Dominelli BSc, MD, FRCPC Kelowna Respiratory and Allergy Clinic
Basic approach to PFT interpretation Dr. Giulio Dominelli BSc, MD, FRCPC Kelowna Respiratory and Allergy Clinic Disclosures Received honorarium from Astra Zeneca for education presentations Tasked Asked
More informationResting handgrip force and impaired cardiac function at rest and during exercise in COPD patients
Respiratory Medicine (2011) 105, 748e754 available at www.sciencedirect.com journal homepage: www.elsevier.com/locate/rmed Resting handgrip force and impaired cardiac function at rest and during exercise
More informationPulmonary Function Testing The Basics of Interpretation
Pulmonary Function Testing The Basics of Interpretation Jennifer Hale, M.D. Valley Baptist Family Practice Residency Objectives Identify the components of PFTs Describe the indications Develop a stepwise
More informationLecture Notes. Chapter 4: Chronic Obstructive Pulmonary Disease (COPD)
Lecture Notes Chapter 4: Chronic Obstructive Pulmonary Disease (COPD) Objectives Define COPD Estimate incidence of COPD in the US Define factors associated with onset of COPD Describe the clinical features
More informationInterpreting pulmonary function tests: Recognize the pattern, and the diagnosis will follow
REVIEW FEYROUZ AL-ASHKAR, MD Department of General Internal Medicine, The Cleveland Clinic REENA MEHRA, MD Department of Pulmonary and Critical Care Medicine, University Hospitals, Cleveland PETER J. MAZZONE,
More informationPrapaporn Pornsuriyasak, M.D. Pulmonary and Critical Care Medicine Ramathibodi Hospital
Prapaporn Pornsuriyasak, M.D. Pulmonary and Critical Care Medicine Ramathibodi Hospital Only 20-30% of patients with lung cancer are potential candidates for lung resection Poor lung function alone ruled
More informationDECLINE OF RESTING INSPIRATORY CAPACITY IN COPD: THE IMPACT ON BREATHING PATTERN, DYSPNEA AND VENTILATORY CAPACITY DURING EXERCISE
Page 1 of 29 Body of text word count: 2,836 Abstract word count: 250 DECLINE OF RESTING INSPIRATORY CAPACITY IN COPD: THE IMPACT ON BREATHING PATTERN, DYSPNEA AND VENTILATORY CAPACITY DURING EXERCISE Authors:
More informationCardiopulmonary Exercise Test (CPET) Evaluation Report
Cardiopulmonary Exercise Test (CPET) Evaluation Report Name: Sally Alpha Date: Test 1 November 29, 2015 Test 2 November 30, 2015 Findings: Sally Alpha demonstrates poor functional capacity and early onset
More information1. When a patient fails to ventilate or oxygenate adequately, the problem is caused by pathophysiological factors such as hyperventilation.
Chapter 1: Principles of Mechanical Ventilation TRUE/FALSE 1. When a patient fails to ventilate or oxygenate adequately, the problem is caused by pathophysiological factors such as hyperventilation. F
More informationEvaluating dyspnea: A practical approach -- When to consider cardiopulmonary exercise testing.
Evaluating dyspnea: A practical approach -- When to consider cardiopulmonary exercise testing. ABSTRACT: Shortness of breath is a common complaint associated with a number of conditions. Although the results
More informationThe Role of CPET (cardiopulmonary exercise testing) in Assessing Lung Disease in CF
The Role of CPET (cardiopulmonary exercise testing) in Assessing Lung Disease in CF Dr. Meir Mei-Zahav Kathy and Lee Graub CF Center Schneider CMCI 1 תאריך Exercise in CF You are probably quite sure that
More informationtodays practice of cardiopulmonary medicine
todays practice of cardiopulmonary medicine Concepts and Applications of Cardiopulmonary Exercise Testing* Karl T. Weber, M.D.; Joseph S. Janicki, Ph.D.; Patricia A. McElroy, M.D.; and Hanumanth K. Reddy,
More informationDoes the multidimensional grading system (BODE) correspond to differences in health status of patients with COPD?
AUTHOR COPY ORIGINAL RESEARCH Does the multidimensional grading system (BODE) correspond to differences in health status of patients with COPD? Kian-Chung Ong 1 Suat-Jin Lu 1 Cindy Seok-Chin Soh 2 1 Department
More informationPulmonary Function Testing
In the Clinic Pulmonary Function Testing Hawa Edriss MD, Gilbert Berdine MD The term PFT encompasses three different measures of lung function: spirometry, lung volumes, and diffusion capacity. In this
More informationLung Function Basics of Diagnosis of Obstructive, Restrictive and Mixed Defects
Lung Function Basics of Diagnosis of Obstructive, Restrictive and Mixed Defects Use of GOLD and ATS Criteria Connie Paladenech, RRT, RCP, FAARC Benefits and Limitations of Pulmonary Function Testing Benefits
More informationCOMPARISON BETWEEN INTERCOSTAL STRETCH AND BREATHING CONTROL ON PULMONARY FUNCTION PARAMETER IN SMOKING ADULTHOOD: A PILOT STUDY
COMPARISON BETWEEN INTERCOSTAL STRETCH AND BREATHING CONTROL ON PULMONARY FUNCTION PARAMETER IN SMOKING ADULTHOOD: A PILOT STUDY Shereen Inkaew 1 Kamonchat Nalam 1 Panyaporn Panya 1 Pramook Pongsuwan 1
More informationPULMONARY FUNCTION TESTS
Chapter 4 PULMONARY FUNCTION TESTS M.G.Rajanandh, Department of Pharmacy Practice, SRM College of Pharmacy, SRM University. OBJECTIVES Review basic pulmonary anatomy and physiology. Understand the reasons
More informationIn patients with symptomatic COPD, desirable. Assessment of Bronchodilator Efficacy in Symptomatic COPD* Is Spirometry Useful?
Assessment of Bronchodilator Efficacy in Symptomatic COPD* Is Spirometry Useful? Denis E. O Donnell, MD, FCCP Bronchodilator therapy in COPD is deemed successful if it improves ventilatory mechanics to
More informationAccuracy of pulmonary function tests in predicted exercise capacity in COPD patients
Respiratory Medicine (2005) 99, 609 614 Accuracy of pulmonary function tests in predicted exercise capacity in COPD patients G. Efremidis a, M. Tsiamita a, A. Manolis b, K. Spiropoulos a, a Division of
More informationPulmonary Rehabilitation in Chronic Lung Disease; Components and Organization. Prof. Dr. Müzeyyen Erk Cerrahpaşa Medical Faculty Chest Disease Dept.
Pulmonary Rehabilitation in Chronic Lung Disease; Components and Organization Prof. Dr. Müzeyyen Erk Cerrahpaşa Medical Faculty Chest Disease Dept. Plan Chronic Respiratory Disease Definition Factors Contributing
More informationJosh Stanton and Michael Epton Respiratory Physiology Laboratory, Canterbury Respiratory Research Group Christchurch Hospital
Josh Stanton and Michael Epton Respiratory Physiology Laboratory, Canterbury Respiratory Research Group Christchurch Hospital Setting Scene Advancements in neonatal care over past 30 years has resulted
More informationLab 4: Respiratory Physiology and Pathophysiology
Lab 4: Respiratory Physiology and Pathophysiology This exercise is completed as an in class activity and including the time for the PhysioEx 9.0 demonstration this activity requires ~ 1 hour to complete
More informationThis is a cross-sectional analysis of the National Health and Nutrition Examination
SUPPLEMENTAL METHODS Study Design and Setting This is a cross-sectional analysis of the National Health and Nutrition Examination Survey (NHANES) data 2007-2008, 2009-2010, and 2011-2012. The NHANES is
More informationRelationship between the Severity of Airway Obstruction and Inspiratory Muscles Dysfunction in COPD Patients
ORIGINAL ARTICLE Tanaffos (2009) 8(3), 37-42 2009 NRITLD, National Research Institute of Tuberculosis and Lung Disease, Iran Relationship between the Severity of Airway Obstruction and Inspiratory Muscles
More informationBenefi ts of short inspiratory muscle training on exercise capacity, dyspnea, and inspiratory fraction in COPD patients
ORIGINAL RESEARCH Benefi ts of short inspiratory muscle training on exercise capacity, dyspnea, and inspiratory fraction in COPD patients Barakat Shahin 1 Michele Germain 2 Alzahouri Kazem 3 Guy Annat
More informationPulmonary rehabilitation in severe COPD.
Pulmonary rehabilitation in severe COPD daniel.langer@faber.kuleuven.be Content Rehabilitation (how) does it work? How to train the ventilatory limited patient? Chronic Obstructive Pulmonary Disease NHLBI/WHO
More informationAnnual Congress of the European Society of Cardiology Munich, August
Annual Congress of the European Society of Cardiology Munich, August 26 2012 Gas exchange measurements during exercise show early pulmonary arterial hypertension in scleroderma patients Daniel Dumitrescu,
More informationPrimary pulmonary hypertension (PPH) is a progressive
Exercise Pathophysiology in Patients With Primary Pulmonary Hypertension Xing-Guo Sun, MD; James E. Hansen, MD; Ronald J. Oudiz, MD; Karlman Wasserman, MD, PhD Background Patients with primary pulmonary
More informationBi-Level Therapy: Boosting Comfort & Compliance in Apnea Patients
Bi-Level Therapy: Boosting Comfort & Compliance in Apnea Patients Objectives Describe nocturnal ventilation characteristics that may indicate underlying conditions and benefits of bilevel therapy for specific
More informationRole of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest
Eur Respir J 2; 16: 269±275 Printed in UK ± all rights reserved Copyright #ERS Journals Ltd 2 European Respiratory Journal ISSN 93-1936 Role of inspiratory capacity on exercise tolerance in COPD patients
More informationJames E. Hansen, MD, FCCP; Gaye Ulubay, MD; Bing Fai Chow, MD; Xing-Guo Sun, MD; and Karlman Wasserman, PhD, MD, FCCP
CHEST Original Research EXERCISE TESTING Mixed-Expired and End-Tidal CO 2 Distinguish Between Ventilation and Perfusion Defects During Exercise Testing in Patients With Lung and Heart Diseases* James E.
More informationIncreased oxygen pulse after lung volume reduction surgery is associated with reduced dynamic hyperinflation
Eur Respir J 1; 4: 837 843 DOI: 1.1183/931936.169311 CopyrightßERS 1 Increased oxygen pulse after lung volume reduction surgery is associated with reduced dynamic hyperinflation Matthew R. Lammi*, David
More informationPatients with right-to-left intracardiac shunts regulate arterial
Gas Exchange Detection of Exercise-Induced Right-to-Left Shunt in Patients With Primary Pulmonary Hypertension Xing-Guo Sun, MD; James E. Hansen, MD; Ronald J. Oudiz, MD; Karlman Wasserman, MD, PhD Background
More informationApproach to CPET. CPET Cases. Case 1 4/4/2018. Impaired? Cardiac factors? Ventilatory factors?
Approach to CPET CPET Cases Neil MacIntyre MD Duke University Medical Center Durham NC Impaired? Work,, /kg Cardiac factors?, /, BP, Rhythm Ventilatory factors? Ve/MVV (incl EIB, trapping), PaCO2 Gas exchange
More informationKey words: cycle ergometer; 1-min step exercise protocol; ramp exercise protocol
Comparison of the Peak Exercise Response Measured by the Ramp and 1-min Step Cycle Exercise Protocols in Patients With Exertional Dyspnea* Sue M. Revill, PhD; Katy E. Beck, BSc; and Mike D. L. Morgan,
More informationبسم هللا الرحمن الرحيم
بسم هللا الرحمن الرحيم Yesterday we spoke of the increased airway resistance and its two examples: 1) emphysema, where we have destruction of the alveolar wall and thus reducing the area available for
More informationCOMPREHENSIVE RESPIROMETRY
INTRODUCTION Respiratory System Structure Complex pathway for respiration 1. Specialized tissues for: a. Conduction b. Gas exchange 2. Position in respiratory pathway determines cell type Two parts Upper
More informationMaximal cardiopulmonary testing has increased
Utility of the Breathing Reserve Index at the Anaerobic Threshold in Determining Ventilatory-Limited Exercise in Adult Cystic Fibrosis Patients* William P. Sexauer, MD, FCCP; Ho-Kan Cheng, MD; and Stanley
More informationB reathlessness is the most disabling symptom associated
8 CHRONIC OBSTRUCTIVE PULMONARY DISEASE Effect of oxygen on recovery from maximal exercise in patients with chronic obstructive pulmonary disease N J Stevenson, P M A Calverley... See end of article for
More informationEffect of N-Acetylcysteine on Air Trapping in COPD. A Randomized Placebo-Controlled Study
CHEST Effect of N-Acetylcysteine on Air Trapping in COPD A Randomized Placebo-Controlled Study David Stav, MD; and Meir Raz, MD Original Research COPD Background: FEV 1 is used for the classification of
More informationSGRQ Questionnaire assessing respiratory disease-specific quality of life. Questionnaire assessing general quality of life
SUPPLEMENTARY MATERIAL e-table 1: Outcomes studied in present analysis. Outcome Abbreviation Definition Nature of data, direction indicating adverse effect (continuous only) Clinical outcomes- subjective
More informationPULMONARY FUNCTION TEST(PFT)
PULMONARY FUNCTION TEST(PFT) Objectives: By the end of the present lab, students should be able to: 1. Record lung volumes and capacities and compare them with those of a typical person of the same gender,
More informationTesting Clinical Implications
Cardiopulmonary Exercise Testing Clinical Implications Dr Sahajal Dhooria Outline Basic concepts Case studies Recent advances in clinical applications of CPET Basic Concepts Exercise Any physical activity
More informationChronic Obstructive Pulmonary Disease (COPD) Clinical Guideline
Chronic Obstructive Pulmonary Disease (COPD) Clinical These clinical guidelines are designed to assist clinicians by providing an analytical framework for the evaluation and treatment of patients. They
More informationBronchodilator responsiveness in patients with COPD
Eur Respir J 28; 31: 742 75 DOI: 1.1183/931936.12967 CopyrightßERS Journals Ltd 28 Bronchodilator responsiveness in patients with COPD D.P. Tashkin*, B. Celli #, M. Decramer ", D. Liu +, D. Burkhart +,
More informationLung Pathophysiology & PFTs
Interpretation of Pulmonary Function Tests (PFTs) Course # 1612 2:00 5:00pm Friday February 22, 2013 Lung Pathophysiology & PFTs Mark F. Sands MD, FCCP, FAAAAI Division of Allergy, Immunology & Rheumatology
More informationRespiratory Pathophysiology Cases Linda Costanzo Ph.D.
Respiratory Pathophysiology Cases Linda Costanzo Ph.D. I. Case of Pulmonary Fibrosis Susan was diagnosed 3 years ago with diffuse interstitial pulmonary fibrosis. She tries to continue normal activities,
More informationChapter 3. Pulmonary Function Study Assessments. Mosby items and derived items 2011, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Chapter 3 Pulmonary Function Study Assessments 1 Introduction Pulmonary function studies are used to: Evaluate pulmonary causes of dyspnea Differentiate between obstructive and restrictive pulmonary disorders
More informationCh 16 A and P Lecture Notes.notebook May 03, 2017
Table of Contents # Date Title Page # 1. 01/30/17 Ch 8: Muscular System 1 2. 3. 4. 5. 6. 7. 02/14/17 Ch 9: Nervous System 12 03/13/17 Ch 10: Somatic and Special Senses 53 03/27/17 Ch 11: Endocrine System
More informationLecture Notes. Chapter 3: Asthma
Lecture Notes Chapter 3: Asthma Objectives Define asthma and status asthmaticus List the potential causes of asthma attacks Describe the effect of asthma attacks on lung function List the clinical features
More informationCardiopulmonary Exercise Testing (CPET) & Evaluating Functional Capacity
Cardiopulmonary Exercise Testing (CPET) & Evaluating Functional Capacity Staci R. Stevens, MA Executive Director Pacific Fatigue Laboratory University of the Pacific sstevens@pacific.edu Christopher Snell,
More informationOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO
OOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO Subject Index ACE inhibitors, see Angiotensin-converting enzyme inhibitors Aging
More informationPathophysiology Department
UNIVERSITY OF MEDICINE - PLOVDIV Pathophysiology Department 15A Vasil Aprilov Blvd. Tel. +359 32 602311 Algorithm for interpretation of submaximal exercise tests in children S. Kostianev 1, B. Marinov
More informationS P I R O M E T R Y. Objectives. Objectives 3/12/2018
S P I R O M E T R Y Dewey Hahlbohm, PA-C, AE-C Objectives To understand the uses and importance of spirometry testing To perform spirometry testing including reversibility testing To identify normal and
More informationPulmonary Pathophysiology
Pulmonary Pathophysiology 1 Reduction of Pulmonary Function 1. Inadequate blood flow to the lungs hypoperfusion 2. Inadequate air flow to the alveoli - hypoventilation 2 Signs and Symptoms of Pulmonary
More informationS everal lines of evidence suggest that gas diffusion across
453 CARDIOVASCULAR MEDICINE Does lung diffusion impairment affect exercise capacity in patients with heart failure? P G Agostoni M Bussotti P Palermo M Guazzi... See end of article for authors affiliations...
More informationKey words: computer administration; continuous method for rating breathlessness; exercise testing
Comparison of Continuous and Discrete Measurements of Dyspnea During Exercise in Patients With COPD and Normal Subjects* Gustavo Fierro-Carrion, MD; Donald A. Mahler, MD, FCCP; Joseph Ward, RCPT; and John
More informationAsthma Management Introduction, Anatomy and Physiology
Asthma Management Introduction, Anatomy and Physiology University of Utah Center for Emergency Programs and The Utah Asthma Program Incidence, Impact and Goals of Asthma Management Prevalence, Morbidity
More informationPathophysiology of COPD 건국대학교의학전문대학원
Pathophysiology of COPD 건국대학교의학전문대학원 내과학교실 유광하 Rate per 100 0,000 population 550 500 450 400 350 300 250 200 150 100 50 0 Heart disease Cancer Stroke 1970 1974 1978 1982 1986 1990 1994 1998 2002 Year of
More informationDOES SMOKING MARIJUANA INCREASE THE RISK OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE?
DOES SMOKING MARIJUANA INCREASE THE RISK OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE Pubdate: Tue, 14 Apr 2009 Source: Canadian Medical Association Journal (Canada) Copyright: 2009 Canadian Medical Association
More informationPerformance Enhancement. Cardiovascular/Respiratory Systems and Athletic Performance
Performance Enhancement Cardiovascular/Respiratory Systems and Athletic Performance Functions of the Cardiovascular System Deliver oxygen & nutrients to body tissues Carry wastes from the cells Anatomy
More informationThe Aging Lung. Sidney S. Braman MD FACP FCCP Professor of Medicine Brown University Providence RI
The Aging Lung Sidney S. Braman MD FACP FCCP Professor of Medicine Brown University Providence RI Is the respiratory system of the elderly different when compared to younger age groups? Respiratory Changes
More informationRecognizing and Correcting Patient-Ventilator Dysynchrony
2019 KRCS Annual State Education Seminar Recognizing and Correcting Patient-Ventilator Dysynchrony Eric Kriner BS,RRT Pulmonary Critical Care Clinical Specialist MedStar Washington Hospital Center Washington,
More informationKey words: exercise capacity; heart failure; hemodynamics; inspiratory capacity; lung function; peak oxygen uptake
Resting Lung Function and Hemodynamic Parameters as Predictors of Exercise Capacity in Patients With Chronic Heart Failure* Serafim Nanas, MD; John Nanas, MD, PhD; Ourania Papazachou, MD; Christos Kassiotis,
More informationCourse Handouts & Disclosure
COPD: Disease Trajectory and Hospice Eligibility Terri L. Maxwell PhD, APRN VP, Strategic Initiatives Weatherbee Resources Hospice Education Network Course Handouts & Disclosure To download presentation
More informationValidation and comparison of reference equations for the 6-min walk distance test
Eur Respir J 2008; 31: 571 578 DOI: 10.1183/09031936.00104507 CopyrightßERS Journals Ltd 2008 Validation and comparison of reference equations for the 6-min walk distance test C.G. Cote, C. Casanova, J.M.
More informationC hronic obstructive pulmonary disease (COPD) is a
288 CHRONIC OBSTRUCTIVE PULMONARY DISEASE Altered thoracic gas compression contributes to improvement in spirometry with lung volume reduction surgery A Sharafkhaneh, S Goodnight-White, T M Officer, J
More informationRESPIRATORY PHYSIOLOGY Pre-Lab Guide
RESPIRATORY PHYSIOLOGY Pre-Lab Guide NOTE: A very useful Study Guide! This Pre-lab guide takes you through the important concepts that where discussed in the lab videos. There will be some conceptual questions
More informationSpirometry. Obstruction. By Helen Grim M.S. RRT. loop will have concave appearance. Flows decreased consistent with degree of obstruction.
1 2 Spirometry By Helen Grim M.S. RRT 3 4 Obstruction loop will have concave appearance. Flows decreased consistent with degree of obstruction. Volumes may be normal, but can decrease with severity of
More informationFarmaci inalatori e dispnea nell asma e nella BPCO. Federico Lavorini
Farmaci inalatori e dispnea nell asma e nella BPCO Federico Lavorini Dept. Experimental and Clinical Medicine Careggi University Hospital Florence - Italy Presenter Disclosures F.L. has received in the
More informationSpirometry: an essential clinical measurement
Shortness of breath THEME Spirometry: an essential clinical measurement BACKGROUND Respiratory disease is common and amenable to early detection and management in the primary care setting. Spirometric
More informationTORCH: Salmeterol and Fluticasone Propionate and Survival in COPD
TORCH: and Propionate and Survival in COPD April 19, 2007 Justin Lee Pharmacy Resident University Health Network Outline Overview of COPD Pathophysiology Pharmacological Treatment Overview of the TORCH
More informationExercise 7: Respiratory System Mechanics: Activity 1: Measuring Respiratory Volumes and Calculating Capacities Lab Report
Exercise 7: Respiratory System Mechanics: Activity 1: Measuring Respiratory Volumes and Calculating Capacities Lab Report Pre-lab Quiz Results You scored 100% by answering 5 out of 5 questions correctly.
More informationExercise tests are commonly used in clinical practice for
Exercise in Cardiovascular Disease Cardiopulmonary Exercise Testing in the Clinical Evaluation of Patients With Heart and Lung Disease Ross Arena, PhD, PT, FAHA; Kathy E. Sietsema, MD Exercise tests are
More informationCORRELATION OF PULMONARY FUNCTION TESTS WITH BODY FAT PERCENTAGE IN YOUNG INDIVIDUALS
Indian J Physiol Pharmacol 2008; 52 (4) : 383 388 CORRELATION OF PULMONARY FUNCTION TESTS WITH BODY FAT PERCENTAGE IN YOUNG INDIVIDUALS ANURADHA R. JOSHI*, RATAN SINGH AND A. R. JOSHI Department of Physiology,
More informationI Can t Breathe! Physiology and Evaluation of the Dyspneic Patient. Christopher Parker, MD Pulmonology, Norman Regional Health Systems
I Can t Breathe! Physiology and Evaluation of the Dyspneic Patient Christopher Parker, MD Pulmonology, Norman Regional Health Systems Photo by James Heilman, MD / CC BY-SA 3.0 Disclosures No Financial
More informationInterval versus continuous training in patients with severe COPD: a randomized clinical trial
Eur Respir J 1999; 14: 258±263 Printed in UK ± all rights reserved Copyright #ERS Journals Ltd 1999 European Respiratory Journal ISSN 0903-1936 Interval versus continuous training in patients with severe
More informationRespiratory System. Chapter 9
Respiratory System Chapter 9 Air Intake Air in the atmosphere is mostly Nitrogen (78%) Only ~21% oxygen Carbon dioxide is less than 0.04% Air Intake Oxygen is required for Aerobic Cellular Respiration
More informationSupplementary Online Content
Supplementary Online Content Regan EA, Lynch DA, Curran-Everett D, et al; Genetic Epidemiology of COPD (COPDGene) Investigators. Clinical and radiologic disease in smokers with normal spirometry. Published
More informationObjective: Prepare NBRC candidate for CRT and WRT Content Outline
STRESS TEST AND HEMODYNAMICS Lois Rowland, MS, RRT-NPS, RPFT, FAARC Objective: Prepare NBRC candidate for CRT and WRT Content Outline Perform, evaluate patient response to, interpret results from: Stress
More information11/12/2018. Prof. Steven S. Saliterman. Options. Prof. Paul Iaizzo s Physiology Lab, PHSL 3701
Department of Biomedical Engineering, University of Minnesota http://saliterman.umn.edu/ Prof. Paul Iaizzo s Physiology Lab, PHSL 3701 Options University of Minnesota Bricker, E. Compass, 5 Types of Cardiac
More information